Bio Green Med Solution Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Bio Green Med Solution Inc.
Former names: Cyclacel Pharmaceuticals, Inc. Xcyte Therapies Inc
Ownership: Public
Status: Active
Sector (GICS): Industrials
SIC code: 5099 — Wholesale-Durable Goods, NEC
Jurisdiction of incorporation: Delaware
Headquarters city: Berkeley Heights
Headquarters state / province: New Jersey
Headquarters country: United States
Fiscal year end: December
Ticker symbol: BGMS
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001130166
EIN: 91-1766850
Wikidata ID: Q5198104

Board of directors

Follow this board

Avraham Ben-Tzvi · Director Overboarded
Since 2025
Brian Schwartz · Director · Interim Chief Medical Officer
Since 2023
Christopher S. Henney · Director
Since 2023
Cu Seng Kiu · Director · Chief Financial Officer
Since 2025
David E. Lazar · Director · Chief Executive Officer Overboarded
Since 2025
David Natan · Director Overboarded
Since 2025
Inigo Angel Laurduraj · Director
Since 2025
Karin L. Walker · Director
Since 2023
Kenneth M. Ferguson · Director
Since 2023
Krishnan Satis Waran Nair · Director
Since 2025
Kwang Fock Chong · Director
Since 2025
Paul McBarron · Director · See Remarks
Since 2023
Robert J. Spiegel · Director
Since 2023
Sam L. Barker · Director
Since 2023
Spiro George Rombotis · Director · President and CEO
Since 2023
Wong Sing Ee Doris · Director · Chief Executive Officer
Since 2025

Chief executives

David E. Lazar · Chief Executive Officer

Since January 2025

Wong Sing Ee Doris · Chief Executive Officer

Since February 2025

Spiro George Rombotis · President and CEO

Until February 2025 · Former

Director election results

Annual meeting of June 21, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 16 other boards. 1 is in the same sector.

Shared director Other board Same sector

ARC Group Acquisition I Corp
via Inigo Angel Laurduraj, Krishnan Satis Waran Nair and Wong Sing Ee Doris
Aterian Inc.
via Avraham Ben-Tzvi, David E. Lazar and David Natan
FiEE Inc
via Avraham Ben-Tzvi, David E. Lazar and David Natan
Indaptus Therapeutics Inc.
via Avraham Ben-Tzvi, David E. Lazar and David Natan
Quantum Cyber N.V.
via Avraham Ben-Tzvi, David E. Lazar and David Natan
LQR House Inc.
via Avraham Ben-Tzvi and David E. Lazar
Sow Good Inc.
via David E. Lazar and David Natan
Black Titan Corporation
via Avraham Ben-Tzvi
Ernexa Therapeutics Inc.
via Robert J. Spiegel
Geron Corporation
via Robert J. Spiegel
Highway Holdings Limited Same sector
via David E. Lazar
KALA BIO Inc.
via David E. Lazar
Lexicon Pharmaceuticals Inc.
via Sam L. Barker
RenovoRx Inc.
via Robert J. Spiegel
Stablecoin Development Corporation
via David E. Lazar
Sunshine Biopharma Inc.
via David Natan

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Nov 12, 2025	Cu Seng Kiu Director, Officer (Chief Financial Officer)	Grant or award	+200,000	$1.40	$280,000
Nov 12, 2025	Wong Sing Ee Doris Director, Officer (Chief Executive Officer), 10% owner	Grant or award	+300,178	$1.40	$420,249
Nov 5, 2025	Kua Khai Loon 10% owner	Other	+467,535	—	—
Nov 5, 2025	Yap Kim Choy 10% owner	Open-market sale	−28,540	$1.70	$48,518
Nov 5, 2025	Ong Yee Lung 10% owner	Other	+467,535	—	—
Nov 5, 2025	Yap Kim Choy 10% owner	Other	+467,535	—	—
Oct 30, 2025	Yap Kim Choy 10% owner	Open-market sale	−112,260	$1.81	$203,191
Oct 30, 2025	Kua Khai Loon 10% owner	Open-market sale	−242,477	$1.80	$436,459
Oct 30, 2025	Ong Yee Lung 10% owner	Open-market sale	−248,814	$1.80	$447,865
Oct 29, 2025	Yap Kim Choy 10% owner	Open-market sale	−110,749	$1.83	$202,671
Oct 28, 2025	Yap Kim Choy 10% owner	Open-market sale	−13,111	$1.83	$23,993
Oct 27, 2025	Yap Kim Choy 10% owner	Open-market sale	−120,250	$2.12	$254,930
Oct 24, 2025	Ong Yee Lung 10% owner	Open-market sale	−19,858	$1.99	$39,517
Oct 24, 2025	Yap Kim Choy 10% owner	Open-market sale	−19,595	$1.90	$37,231
Oct 21, 2025	FITTERS Diversified Berhad 10% owner	Open-market sale	−92,352	$3.01	$277,980

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

AAR Corp. NYSE: AIR · Wood Dale, United States Organization ABM Industries Incorporated NYSE: ABM · New York, United States Organization ADI Global Distribution Inc. NYSE: ADIG · Wilmington, United States Organization ADT Inc. NYSE: ADT · Boca Raton, United States Organization

Questions about Bio Green Med Solution Inc.

Who is the CEO of Bio Green Med Solution Inc.?

Wong Sing Ee Doris has been Bio Green Med Solution Inc.'s Chief Executive Officer since February 2025.

How many directors are on Bio Green Med Solution Inc.'s board?

Bio Green Med Solution Inc.'s board has 16 directors: Avraham Ben-Tzvi, Brian Schwartz, Christopher S. Henney, Cu Seng Kiu, David E. Lazar, David Natan, Inigo Angel Laurduraj, Karin L. Walker, Kenneth M. Ferguson, Krishnan Satis Waran Nair and 6 others.

How is Bio Green Med Solution Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="bio-green-med-solution-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.